Enslin MB

No ORCID on file · 2 papers in corpus

2018

Single- and Multiple-Day Dosing Studies to Investigate High-Dose Pharmacokinetics of Epelsiban and Its Metabolite, GSK2395448, in Healthy Female Volunteers.

Clinical pharmacology in drug development ·doi:10.1002/cpdd.363

Open-label single- and double-blind repeat-dose studies in healthy female volunteers were conducted to investigate the pharmacokinetics (PK) and safety/tolerability of epelsiban total daily doses ranging from 600 to 900 mg. In 1 study (n = …

article 2017

Experience of Symptoms and Disease Impact in Patients with Adenomyosis

The patient ·doi:10.1007/s40271-017-0284-2

BACKGROUND: Adenomyosis is a poorly understood, benign disease of the uterus. OBJECTIVE: In this study, patient interviews were conducted to characterize the symptoms and impact of adenomyosis. METHODS: This was a cross-sectional study in w…